

Neurofibromatosis type 1 or von Recklinghausen's disease is an autosomal dominant disease. Neurofibromatosis type 1 presents with neurofibromas, cafe-au-lait macules, freckling, and optic gliomas. Neurofibromatosis types 1 and 2 are the most common and are distinct entities. Neurofibromatosis is a neurocutaneous disorder characterized by tumors in the nervous system and skin. Explain interprofessional team strategies for improving care coordination and communication to advance the treatment of neurofibromatosis and improve outcomes.

Summarize the treatment and management options available for neurofibromatosis.Describe the presentation of a patient with neurofibromatosis.Identify the etiology of neurofibromatosis.This activity describes the pathophysiology, evaluation, and management of neurofibromatosis and highlights the role of the interprofessional team in caring for patients affected by this condition. Treatment for neurofibromatosis types 1 and 2 involves clinical monitoring and medical intervention when appropriate. Neurofibromatosis type 2 is characterized by bilateral vestibular schwannomas and meningiomas. Neurofibromatosis type 1, also known as von Recklinghausen's disease presents with neurofibromas, cafe-au-lait spots, freckling, and optic gliomas. The most common types of neurofibromatosis are types 1 and 2, both of which are autosomal dominant.
